In early April, the World Health Organization reported a total of 30 Ebola cases in a week, the fewest in just under a year. Yet even as the epidemic wound down, it continued to inflict pain. More than 25,000 people have been infected since December 2013, according to the official count. About 10,000 have died, leaving behind an estimated 30,000 orphans. More will perish, given a fatality rate of 70 percent in this outbreak. The economic disruption caused by Ebola cost the three countries more than half a billion dollars in 2014, almost five percent of their combined GDPs, according to the World Bank. Aversion to medical facilities has wrecked malaria-control efforts, raising concerns about a malaria surge. Coping even with mundane medical needs is a challenge given the estimated 500 health-care workers killed by Ebola so far. With better medical systems, Nigeria, Senegal and Mali contained Ebola when it spread there, and the Democratic Republic of Congo controlled an outbreak of a different strain of the virus. Two medical workers in the U.S. and one in Spain were infected after caring for people who had contracted Ebola in Africa; all three recovered.
Earlier Ebola outbreaks, which produced a total of 2,387 cases and 1,590 deaths since 1976, were contained within months. Those occurred largely in remote rural areas. This epidemic, however, began at a crossroads where people move frequently across porous borders in search of work or food, and cities became centers of contagion. It was Ebola’s first appearance in western Africa, in three of the world’s poorest countries. Early on, the disease was transmitted by victims who avoided hospitals because of stigma and fear, as well as by unsafe burial practices. The countries’ relatively rare health workers – Liberia has just 1 doctor per 100,000 people – were unprepared to deal with the patients they saw. A few foreign volunteer groups pitched in, but the WHO was slow to recognize and respond to the threat. The U.S., beginning in September, sent 2,800 military personnel to Liberia to help fight the outbreak; about half had returned home by February. There are no drugs or vaccines approved to treat or prevent Ebola, although companies and government-funded labs have accelerated their development. Ebola jumps to humans through contact with secretions from animals such as chimpanzees, gorillas and bats. It spreads among humans the same way, with medical workers and family members the most at risk.
Ebola doesn’t travel through the air, making it harder to transmit than many other pathogens as long as proper health-care practices are followed. Thus, the disease’s tear through three impoverished countries raises questions about whether richer nations should focus their aid more on strengthening health-care systems. Assistance programs are often directed instead at combating a particular disease. Defenders of this approach say it gets quicker results, which are measurable. Critics say it creates a duplication of services for different diseases, and leaves few resources for primary care. For its part, the WHO, acknowledging criticisms of its performance, said it would create a special fund and an emergency workforce to react to crises such as the Ebola outbreak. That change, however, did not address the failure of WHO’s leaders to recognize the need to respond.
The Reference Shelf
- Bloomberg News Q&A on the Ebola outbreak.
- A WHO report examining the response to Ebola one year into the epidemic.
- A report on ethics and Ebola by the U.S. Presidential Commission for the Study of Bioethical Issues.
- Richard Preston’s 1994 best-selling book about Ebola, “The Hot Zone” and Laurie Garrett’s 1995 book “The Coming Plague: Newly Emerging Diseases in a World Out of Balance.”
- A New York Times graphic tracing the latest epidemic.